ラクオリア創薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/10/14 | 1,066 | 1,094 | 1,060 | 1,078 | +22 | +2.1% | 133,200 |
| 2022/10/13 | 1,080 | 1,080 | 1,051 | 1,056 | -18 | -1.7% | 99,100 |
| 2022/10/12 | 1,071 | 1,080 | 1,066 | 1,074 | +3 | +0.3% | 92,500 |
| 2022/10/11 | 1,073 | 1,082 | 1,067 | 1,071 | -17 | -1.6% | 65,300 |
| 2022/10/07 | 1,070 | 1,098 | 1,065 | 1,088 | +10 | +0.9% | 72,400 |
| 2022/10/06 | 1,082 | 1,086 | 1,074 | 1,078 | +8 | +0.7% | 44,400 |
| 2022/10/05 | 1,069 | 1,081 | 1,063 | 1,070 | +9 | +0.8% | 61,100 |
| 2022/10/04 | 1,062 | 1,068 | 1,054 | 1,061 | +17 | +1.6% | 78,000 |
| 2022/10/03 | 1,029 | 1,050 | 1,015 | 1,044 | ±0 | ±0% | 52,200 |
| 2022/09/30 | 1,034 | 1,054 | 1,030 | 1,044 | -2 | -0.2% | 73,300 |
| 2022/09/29 | 1,036 | 1,060 | 1,028 | 1,046 | +35 | +3.5% | 77,300 |
| 2022/09/28 | 1,029 | 1,048 | 1,007 | 1,011 | -19 | -1.8% | 102,000 |
| 2022/09/27 | 1,014 | 1,041 | 1,007 | 1,030 | +24 | +2.4% | 108,000 |
| 2022/09/26 | 1,009 | 1,033 | 1,005 | 1,006 | -28 | -2.7% | 118,700 |
| 2022/09/22 | 1,000 | 1,044 | 999 | 1,034 | +21 | +2.1% | 131,500 |
| 2022/09/21 | 1,030 | 1,035 | 1,002 | 1,013 | -33 | -3.2% | 170,100 |
| 2022/09/20 | 1,084 | 1,085 | 1,036 | 1,046 | -39 | -3.6% | 216,000 |
| 2022/09/16 | 1,095 | 1,099 | 1,076 | 1,085 | -26 | -2.3% | 172,600 |
| 2022/09/15 | 1,135 | 1,135 | 1,109 | 1,111 | -12 | -1.1% | 120,000 |
| 2022/09/14 | 1,120 | 1,153 | 1,119 | 1,123 | -32 | -2.8% | 237,500 |
| 2022/09/13 | 1,149 | 1,163 | 1,138 | 1,155 | +10 | +0.9% | 136,600 |
| 2022/09/12 | 1,149 | 1,153 | 1,131 | 1,145 | +1 | +0.1% | 159,300 |
| 2022/09/09 | 1,099 | 1,157 | 1,098 | 1,144 | +51 | +4.7% | 338,900 |
| 2022/09/08 | 1,114 | 1,114 | 1,081 | 1,093 | +8 | +0.7% | 132,600 |
| 2022/09/07 | 1,116 | 1,116 | 1,075 | 1,085 | -28 | -2.5% | 155,000 |
| 2022/09/06 | 1,078 | 1,131 | 1,073 | 1,113 | +39 | +3.6% | 224,900 |
| 2022/09/05 | 1,040 | 1,074 | 1,018 | 1,074 | +34 | +3.3% | 128,600 |
| 2022/09/02 | 1,052 | 1,057 | 1,010 | 1,040 | -6 | -0.6% | 132,500 |
| 2022/09/01 | 1,062 | 1,062 | 1,040 | 1,046 | -11 | -1% | 125,500 |
| 2022/08/31 | 1,067 | 1,075 | 1,050 | 1,057 | -11 | -1% | 112,400 |
| 2022/08/30 | 1,064 | 1,070 | 1,053 | 1,068 | +8 | +0.8% | 102,000 |
| 2022/08/29 | 1,065 | 1,076 | 1,052 | 1,060 | -30 | -2.8% | 148,300 |
| 2022/08/26 | 1,077 | 1,099 | 1,067 | 1,090 | +14 | +1.3% | 221,300 |
| 2022/08/25 | 1,035 | 1,086 | 1,031 | 1,076 | +51 | +5% | 231,000 |
| 2022/08/24 | 1,020 | 1,045 | 1,006 | 1,025 | -2 | -0.2% | 178,300 |
| 2022/08/23 | 1,000 | 1,043 | 998 | 1,027 | +4 | +0.4% | 319,000 |
| 2022/08/22 | 1,058 | 1,059 | 1,012 | 1,023 | -54 | -5% | 462,100 |
| 2022/08/19 | 1,047 | 1,107 | 1,035 | 1,077 | ±0 | ±0% | 457,200 |
| 2022/08/18 | 1,056 | 1,162 | 1,046 | 1,077 | +8 | +0.7% | 1,850,000 |
| 2022/08/17 | 1,070 | 1,097 | 1,023 | 1,069 | +90 | +9.2% | 3,767,000 |
| 2022/08/16 | 905 | 979 | 905 | 979 | +150 | +18.1% | 1,331,900 |
| 2022/08/15 | 825 | 831 | 815 | 829 | +8 | +1% | 121,500 |
| 2022/08/12 | 815 | 822 | 812 | 821 | +12 | +1.5% | 45,600 |
| 2022/08/10 | 835 | 835 | 807 | 809 | -26 | -3.1% | 97,000 |
| 2022/08/09 | 822 | 836 | 814 | 835 | +13 | +1.6% | 82,800 |
| 2022/08/08 | 816 | 832 | 814 | 822 | +4 | +0.5% | 89,200 |
| 2022/08/05 | 834 | 842 | 818 | 818 | -15 | -1.8% | 111,900 |
| 2022/08/04 | 818 | 838 | 810 | 833 | +23 | +2.8% | 209,900 |
| 2022/08/03 | 804 | 815 | 804 | 810 | +2 | +0.2% | 72,700 |
| 2022/08/02 | 809 | 817 | 806 | 808 | -10 | -1.2% | 51,600 |
701～
750
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
| 大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
| Ｃｈｏｒｄｉａ | 18,000円 | - | - | 0.00% | - | 3.83倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
| セルソース | 62,300円 | - | - | 0.80% | 48.41倍 | 2.09倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム
